Sativa Group and StillCanna’s “Sativa Wellness Group Inc” expected to commence early to mid-September 2020

Sativa Group Plc (AQSE:SATI) and Stillcanna Inc announced that they had agreed the terms of a recommended all-share acquisition of the entire issued and to be issued ordinary share capital of Sativa by Stillcanna. The Acquisition is being implemented by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act.

The Court Meeting to consider and, if thought fit, approve the Scheme and the General Meeting to consider and, if thought fit, pass the Special Resolution relating to the Acquisition were each held yesterday.

The Board of Sativa is pleased to announce that at the Court Meeting held yesterday at 11.00 a.m., the Special Resolution was duly passed with 99% of shares represented voting in favour of the motion and only 1% against.

Further, the Board of Sativa is pleased to announce that at the General Meeting held yesterday at 11.15 a.m., all Resolutions were duly passed again with 99% of shares represented voting in favour of the motion and only 1% against.

Shareholders participating in both of the meetings by proxy held 72% of the total shares.

Effective Date and Timetable

The outcome of the Court Meeting and General Meeting means that Conditions 2(A) to 2(E) (inclusive) (as set out in Section A of Part III of the Scheme Document) have been satisfied.

Completion of the Acquisition remains subject to the satisfaction or, if appropriate, waiver of the other Conditions set out in the Scheme Document, including, amongst other things, the sanction of the Scheme by the Court. The Court Hearing is expected to take place on 28 August 2020. It should be noted that the last day of dealings in, and for registration of transfers of, and disablement in CREST of, Sativa Group Plc shares is expected to be 28 August 2020.

Subject to the Court approving the Scheme and the Court Order being duly delivered to the Registrar of Companies, it is anticipated that the Scheme will become effective on 1 September 2020. 

If the Court sanctions the Scheme it is intended that the admission to trading of Sativa Group Plc shares on AQSE will be cancelled with effect from on 2 September 2020.

Trading of the newly combined company, to be named Sativa Wellness Group Inc., is expected to recommence around early to mid-September 2020, with an application  to be quoted on the AQSE Growth Market commencing around the same time, subject to regulatory approval.

These dates are indicative only and will depend, amongst other things, on the date on which the Court sanctions the Scheme. If the expected dates change, the Company will give notice of the changes in an announcement through a Regulatory Information Service.

Words and expressions defined in the Scheme Document shall, unless the context provides otherwise, have the same meanings in this announcement.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Sativa Group

    More articles like this

    Sativa Group

    Medicinal cannabis: What is it and is it legal in the UK?

    Charlotte Caldwell, the mother of 15-year-old Billy Caldwell, has brought her legal campaign to acquire medicinal cannabis for him through the NHS to an end. Mrs Caldwell and her son made headlines in 2018 when officials at London’s Heathrow

    Sativa Group

    CBD ‘improves blood flow to the brain’

    Cannabidiol (CBD) improves brain blood flow which could help improve memory, researchers have said. The team from the University of College London (UCL) say these findings could potentially contribute to better treatments for conditions like Alzheimer’s disease

    Sativa Group

    More people turn to CBD as its list of applications grows

    There are numerous incredible innovations scientists and researchers have made in biotechnology in recent years. Among the fields of study are gene editing, tissue engineering and regeneration, nanobiotechnology and many others. In addition, new segments under

    Sativa Group

    5 reasons to try CBD oil

    With the legalization of marijuana, people are turning towards it as a treatment for various ailments that they are suffering from in life. Cannabidiol oil or CBD is a byproduct of marijuana and is also gaining

    Sativa Group

    Sativa Group delivers a record month of revenues

    Sativa Group Plc [AQSE:SATI], the UK’s leading quoted CBD wellness and medicinal cannabis company, has recorded a record month of revenues for the Group in July. We are pleased to announce that our strong group sales

    Sativa Group

    Opportunities in the UK’s CBD market

    The UK’s CBD market has flourished despite the impact of COVID-19. The rest of the world has steamed ahead with the legalisation of medical and recreational cannabis creating multibillion-dollar industries, while the UK has watched quietly

    Sativa Group

    Research finds CBD effective at treating cannabis use disorder

    Cannabis affects everyone differently and can create deleterious effects for some individuals. One recent study indicates 30% of marijuana consumers have some degree of cannabis use disorder. These disorders are characterized by dependence. When a user experiences withdrawal

    Sativa Group

    Want to use CBD oil for anxiety?

    Anxiety relief is one of the main reasons why people become interested in CBD, and its anti-anxiety benefits have been well documented. There is, however, so much misinformation out there about CBD products, and it can

    Sativa Group

    The changing landscape of CBD in the UK

    Reports estimate that up to 8 million people in the UK use CBD for its variety of wellness benefits. The market is currently worth £300 million, a figure which is expected to more than triple in

    Sativa Group

    Why CBD-based products could be the future

    There may be over 34 million adult smokers in the US, but nearly 70% of those people are trying to kick the habit. Unfortunately, only a handful are ever successful, regardless if they try to quit

    Sativa Group

    How does CBD affect the immune system and autoimmune disease?

    While more countries around the world continue to acknowledge the potential of CBD, the full biological effects of the cannabinoid are yet to be fully understood. However, some research demonstrates that CBD has anti-inflammatory and immunosuppressive

    Sativa Group

    Sativa Group record month of revenues in June

    Sativa Group Plc [AQSE: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis company, has recorded a record month of revenues for the Group in June. Record sales have been achieved in the month of

    Sativa Group

    CBD Oil for Alzheimer’s & Dementia

    Hemp and CBD oil were federally legalized with the 2018 Farm Bill, but scientists have been researching cannabidiol and its potential benefits for many years prior to the cannabis boom. CBD products are gaining popularity at